These three Nasdaq stocks saw price drops of more than 35% last month. Are they good buys or too risky to touch today?
The stock market saw some bumps and dips in July, but the major market indexes still landed within a few percent of the month’s starting price.
But a few names on the Nasdaq stock exchange fell more than 35% last month. Are they falling knives, best left untouched — or could they be solid buys at a lower price level?
|
Nasdaq Stock |
Industry |
July Return |
52-Week Return |
|---|---|---|---|
|
DexCom (DXCM 3.89%) |
Medical devices |
(40.2%) |
(37.5%) |
|
CrowdStrike (CRWD 4.34%) |
Cybersecurity |
(39.5%) |
53.9% |
|
Helen of Troy (HELE -1.07%) |
Housewares, health, and beauty products |
(36.2%) |
(59.6%) |
Data source: YCharts. 52-week return is through Aug. 6.
DexCom: Poised to perform
Let’s start with the biggest Nasdaq dip in July. Medical devices developer DexCom reported second-quarter results on July 25, and many…
